Figure 3
From: Innovative Biocatalysts as Tools to Detect and Inactivate Nerve Agents
Demonstrator chamber. The inhibitory effect of POX on the EST2 biosensing platform was evaluated by nebulizing the NAS solution (100 µM POX, 100 µM MPOX, 25 µM MPTON), in the demonstrator chamber (2.30 × 2.30 × 2.80 m, Scheme (a) and Real view (b), by using 2 pumps (MGF1 and 2 for enzyme (E) and NAS (S) respectively) and a control system (PLC and see SI).
